Suryakant Niture

Dr. Suryakant Niture

Radiation Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA
+1
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2009 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
JKJames W. Kaspar
James W. Kaspar
Suryakant NitureSuryakant Niture
Suryakant Niture
AJAnil K. Jaiswal
Anil K. Jaiswal

1 January 2014 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
Suryakant NitureSuryakant Niture
Suryakant Niture
RGRaju Ghimire
Raju Ghimire
AJAnil K. Jaiswal
Anil K. Jaiswal

1 March 2012 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
Suryakant NitureSuryakant Niture
Suryakant Niture
AJAnil K. Jaiswal
Anil K. Jaiswal
Nuclear transcription factor Nrf2 regulates the expression and coordinated induction of a battery of genes encoding cytoprotective and drug transporter proteins in response to chemical and radiation stress. This leads to reduced apoptosis, enhanced cell survival, and increased drug resistance. In this study, we investigated the role of Nrf2 in up-regulation of antiapoptotic protein Bcl-2 and its contribution to stress-induced apoptosis and cell survival. Exposure of mouse hepatoma (Hepa-1) and human hepatoblastoma (HepG2) cells to antioxidant tert-butylhydroquinone led to induction of Bcl-2. Mutagenesis and transfection assays identified an antioxidant response element between nucleotides −3148 and −3140 on the reverse strand of the Bcl-2 gene promoter that was essential for activation of Bcl-2 gene expression. Band/supershift and ChIP assays demonstrated binding of Nrf2 to Bcl-2 antioxidant response element. Alterations in Nrf2 led to altered Bcl-2 induction and cellular apoptosis. Moreover, dysfunctional/mutant inhibitor of Nrf2 (INrf2) in human lung cancer cells failed to degrade Nrf2, resulting in an increased Bcl-2 level and decreased etoposide- and UV/γ radiation-mediated DNA fragmentation. In addition, siRNA-mediated down-regulation of Nrf2 also led to decreased apoptosis and increased cell survival. Furthermore, the specific knockdown of Bcl-2 in Nrf2-activated tumor cells led to increased etoposide-induced apoptosis and decreased cell survival and growth/proliferation. These data provide the first evidence of Nrf2 in control of Bcl-2 expression and apoptotic cell death with implications in antioxidant protection, survival of cancer cells, and drug resistance.

1 April 2010 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
Suryakant NitureSuryakant Niture
Suryakant Niture
JKJames W. Kaspar
James W. Kaspar
JSJun Shen
Jun Shen
AJAnil K. Jaiswal
Anil K. Jaiswal

1 April 2013 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
Suryakant NitureSuryakant Niture
Suryakant Niture
AJAnil K. Jaiswal
Anil K. Jaiswal

8 June 2007 in Biochemistry
Verified
Journal Article
Closed access
CVChinavenmeni S. Velu
Chinavenmeni S. Velu
Suryakant NitureSuryakant Niture
Suryakant Niture
CDCatalin E. Doneanu
Catalin E. Doneanu
NPNagarajan Pattabiraman
Nagarajan Pattabiraman
KSKalkunte Srivenugopal
Kalkunte Srivenugopal